Scholarlink

Background <p>Glycolipid dysregulation is a core driver of cardiometabolic multimorbidity (CMM), yet its role as an integrated network in CMM pathogenesis remains unexplored.</p> Objective <p>To explore the association between individual differential glycolipid covariance networks (IDGCNs)—pairwise glycolipid correlation matrix from six glycolipid biomarkers—and incident CMM.</p> Methods <p>We utilized 9-year longitudinal data (2011–2020) from 12,267 middle-aged and older Chinese adults. IDGCNs were constructed from six glycolipid biomarkers-fasting plasma glucose, glycated hemoglobin A1c, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)-and quantified as 6 × 6 partial-correlation matrices, with 15 off-diagonal elements transformed into feature vectors. K-means clustering (k = 3) identified network phenotypes. Fine-Gray subdistribution hazards regression models were used to estimate hazard ratios (HRs) for incident CMM across clusters. The effects of glycolipid-coupling mixtures were evaluated using quantile-based g-computation. The incremental predictive utility was assessed using the C-statistic, net reclassification improvement, integrated discrimination improvement, and likelihood-ratio test.</p> Results <p>During a median follow-up of 9 years, 2,040 participants developed CMM. Relative to the normal group, multivariable-adjusted HRs (95%CI) for incident CMM escalated across clusters: Cluster 1 = 2.321 (1.400–3.850), Cluster 2 = 5.385 (3.155–9.192), and Cluster 3 = 5.845 (3.027–11.284). HDL-related couplings were protective, while glucose–LDL coupling was deleterious factors. The addition of the glycolipid-coupling mixture to conventional risk factors improved predictive metrics significantly.</p> Conclusions <p>Glycolipid network topology independently predicts incident CMM, supporting a shift from single-biomarker thresholds to network-based risk phenotyping.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Data-driven glycolipid network phenotypes reveal a graded risk spectrum for cardiometabolic multimorbidity: a prospective study in middle-aged and older Chinese adults

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月11日

查看全文
  • Zhao-Xuan Lu,
  • Bing-Qing Dong,
  • Liang Chen,
  • Heng-Le Wei,
  • Hong Zhang

摘要

Background

Glycolipid dysregulation is a core driver of cardiometabolic multimorbidity (CMM), yet its role as an integrated network in CMM pathogenesis remains unexplored.

Objective

To explore the association between individual differential glycolipid covariance networks (IDGCNs)—pairwise glycolipid correlation matrix from six glycolipid biomarkers—and incident CMM.

Methods

We utilized 9-year longitudinal data (2011–2020) from 12,267 middle-aged and older Chinese adults. IDGCNs were constructed from six glycolipid biomarkers-fasting plasma glucose, glycated hemoglobin A1c, total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)-and quantified as 6 × 6 partial-correlation matrices, with 15 off-diagonal elements transformed into feature vectors. K-means clustering (k = 3) identified network phenotypes. Fine-Gray subdistribution hazards regression models were used to estimate hazard ratios (HRs) for incident CMM across clusters. The effects of glycolipid-coupling mixtures were evaluated using quantile-based g-computation. The incremental predictive utility was assessed using the C-statistic, net reclassification improvement, integrated discrimination improvement, and likelihood-ratio test.

Results

During a median follow-up of 9 years, 2,040 participants developed CMM. Relative to the normal group, multivariable-adjusted HRs (95%CI) for incident CMM escalated across clusters: Cluster 1 = 2.321 (1.400–3.850), Cluster 2 = 5.385 (3.155–9.192), and Cluster 3 = 5.845 (3.027–11.284). HDL-related couplings were protective, while glucose–LDL coupling was deleterious factors. The addition of the glycolipid-coupling mixture to conventional risk factors improved predictive metrics significantly.

Conclusions

Glycolipid network topology independently predicts incident CMM, supporting a shift from single-biomarker thresholds to network-based risk phenotyping.